Global Director, Biomarkers and CDx at BD
Tony Grover is a medical device and diagnostics executive with over twenty years of experience in commercial strategy, product launch, and reimbursement for disruptive medical device and diagnostics products. He is currently the Global Director of Biomarkers and CDx at BD where he leads the companion diagnostics business for the organization. Previously, he was the Chief Business Development Officer at Drawbridge Health, a remote blood collection device that was acquired by Thorne Health in 2021. He also served as VP of Business Development at Banyan Biomarkers, the company that created first FDA cleared diagnostic blood test for concussions, and was responsible for license deals, strategic investments, and managing alliances with numerous commercial partners that led to an acquisition. He is currently Chairman of the Biocom California Medical Device and Diagnostics Committee and previously served as Chairman of the Board of Directors for the American Heart Association, San Diego.